|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM164570195 |
| 003 |
DE-627 |
| 005 |
20250207124431.0 |
| 007 |
tu |
| 008 |
231223s2006 xx ||||| 00| ||chi c |
| 028 |
5 |
2 |
|a pubmed25n0549.xml
|
| 035 |
|
|
|a (DE-627)NLM164570195
|
| 035 |
|
|
|a (NLM)16887059
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a chi
|
| 100 |
1 |
|
|a Hu, Ping
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Kinetics and mechanism in bleomycin-induced murine pulmonary fibrosis model
|
| 264 |
|
1 |
|c 2006
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 07.12.2010
|
| 500 |
|
|
|a Date Revised 21.11.2013
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a OBJECTIVE: To investigate the kinetics of pathogenesis of bleomycin induced pulmonary fibrosis and its mechanism in mice
|
| 520 |
|
|
|a METHODS: Thirty six male ICR mice were randomized as a negative control (NC) group and pulmonary fibrosis model (FM) groups (FMA, FMB, FMC, FMD, FME sub groups). Except for NC group, mice in the other groups were given bleomycin by nasal instillation. Animals in each group were sacrificed on day 6, 14, 21, 28 and 35, respectively. T lymphocytes were quantified for Th1/Th2 and Tc1/Tc2 by flow cytometry. Accumulation of inflammatory cells in bronchioalveolar lavage fluid (BALF) was quantified by cell count. The sections of the right lung were stained with either hematoxylin eosin (HE) or Masson trichrome. The left lung was weighed and its hydroxyproline (HYP) content was assayed. Multi cytokine expression in lung tissue was assayed by semi quantitative reverse transcription polymerase chain reaction (RT-PCR). On day 35, the tidal volume (V(T)), forced expiratory volume in 1 second/forced vital capacity (FEV 0.1/FVC), static compliance (Cst) of mice were determined before they were sacrificed
|
| 520 |
|
|
|a RESULTS: (1)The total cell number in BALF in pulmonary fibrosis groups was statistically significantly higher than that in NC group (all P<0.01), and HYP content in lung tissue in pulmonary fibrosis groups was statistically significantly increased than that in NC group except for group FMA (all P<0.01). (2)V(T) and Cst in FME group were statistically significantly decreased than those in NC group (both P<0.01), and FEV 0.1/FVC was statistically significantly increased (P<0.05). (3)Th1 and Tc1 were demonstrated as the dominant expression in the acute inflammatory stage; Th2 and Tc2 were the dominant expression in the fibrosis forming stage, and then Th1 and Tc1 were again the dominant expression at the terminal stage of pulmonary fibrosis. (4)Compared with the content of cytokine in the lung in NC group, the expression of transforming growth factor-beta1 (TGF-beta1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) mRNA were significantly higher in FM groups (all P<0.01)
|
| 520 |
|
|
|a CONCLUSION: The changes in lung function of bleomycin-induced pulmonary fibrosis in mice are typical of that of restrictive ventilatory disorder. Th2, Tc2 and fibrotic promoting growth factors (TGF-beta1, TIMP-1, etc.) play pivotal roles in the pathogenesis of pulmonary fibrotic process
|
| 650 |
|
4 |
|a English Abstract
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
7 |
|a Tgfb1 protein, mouse
|2 NLM
|
| 650 |
|
7 |
|a Tissue Inhibitor of Metalloproteinase-1
|2 NLM
|
| 650 |
|
7 |
|a Transforming Growth Factor beta1
|2 NLM
|
| 650 |
|
7 |
|a Bleomycin
|2 NLM
|
| 650 |
|
7 |
|a 11056-06-7
|2 NLM
|
| 650 |
|
7 |
|a Hydroxyproline
|2 NLM
|
| 650 |
|
7 |
|a RMB44WO89X
|2 NLM
|
| 700 |
1 |
|
|a Gao, Zhan-cheng
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
|d 1998
|g 18(2006), 8 vom: 04. Aug., Seite 474-8
|w (DE-627)NLM098227793
|x 1003-0603
|7 nnns
|
| 773 |
1 |
8 |
|g volume:18
|g year:2006
|g number:8
|g day:04
|g month:08
|g pages:474-8
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 18
|j 2006
|e 8
|b 04
|c 08
|h 474-8
|